Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-02-20 Sale |
2024-02-21 9:41 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
24,888 | $14.11 | $351,289 | 395,394 (Direct) |
View |
| 2024-02-14 Sale |
2024-02-16 4:20 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
58,356 | $15.01 | $875,883 | 181,676 (Direct) |
View |
| 2024-02-01 Sale |
2024-02-05 5:55 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
10,000 | $16.22 | $162,198 | 117,532 (Direct) |
View |
| 2023-12-27 Sale |
2023-12-28 4:28 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
30,000 | $12.02 | $360,453 | 127,532 (Direct) |
View |
| 2023-11-20 Sale |
2023-11-21 4:30 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
14,807 | $8.2293 | $121,851 | 271,138 (Direct) |
View |
| 2023-08-18 Sale |
2023-08-21 8:05 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
14,876 | $10.73 | $159,602 | 273,112 (Direct) |
View |
| 2023-05-18 Sale |
2023-05-19 9:17 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
5,627 | $10.14 | $57,083 | 350,489 (Direct) |
View |
| 2023-02-17 Sale |
2023-02-23 5:40 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
6,700 | $7.66 | $51,322 | 196,392 (Direct) |
View |
| 2022-11-18 Sale |
2022-11-21 4:17 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
1,785 | $5.44 | $9,710 | 196,148 (Direct) |
View |
| 2022-09-02 Sale |
2022-09-07 4:50 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
1,320 | $17.01 | $22,458 | 110,858 (Direct) |
View |
| 2022-08-17 Sale |
2022-08-19 4:58 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
1,797 | $14.96 | $26,890 | 203,261 (Direct) |
View |
| 2022-03-09 Sale |
2022-03-11 4:56 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
10,000 | $17.07 | $170,693 | 114,670 (Direct) |
View |
| 2021-10-01 Sale |
2021-10-04 4:57 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
10,000 | $17.18 | $171,841 | 124,670 (Direct) |
View |
| 2021-07-01 Sale |
2021-07-02 5:35 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
10,000 | $24.15 | $241,477 | 134,670 (Direct) |
View |
| 2021-06-17 Sale |
2021-06-22 5:15 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
1,067 | $30.04 | $32,051 | 144,670 (Direct) |
View |
| 2021-06-09 Sale |
2021-06-11 7:29 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
8,933 | $30.05 | $268,480 | 145,737 (Direct) |
View |
| 2021-04-01 Sale |
2021-04-05 6:38 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
10,000 | $27.44 | $274,436 | 159,420 (Direct) |
View |
| 2021-02-23 Sale |
2021-02-25 8:20 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
10,000 | $33.55 | $335,538 | 169,420 (Direct) |
View |
| 2021-01-04 Sale |
2021-01-06 5:33 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
10,000 | $18.19 | $181,904 | 179,420 (Direct) |
View |
| 2020-10-20 Sale |
2020-10-22 5:33 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
38,539 | $17.98 | $693,025 | 195,420 (Direct) |
View |
| 2020-10-16 Sale |
2020-10-20 2:08 pm |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
1,261 | $17.01 | $21,444 | 233,959 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-02-17 Exercise |
2024-02-21 9:41 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
108,830 | $0 | 395,394 (Direct) |
View |
| 2024-02-11 Option Award |
2024-02-13 09:08 am |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
205,833 | $0 | 323,365 (Direct) |
View |
| 2023-11-17 Exercise |
2023-11-21 4:30 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
67,166 | $0 | 271,138 (Direct) |
View |
| 2023-10-30 Gift |
2023-11-01 4:12 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
8,000 | $0 | 138,756 (Direct) |
View |
| 2023-08-17 Exercise |
2023-08-21 8:05 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
67,164 | $0 | 273,112 (Direct) |
View |
| 2023-02-17 Exercise(A) |
2023-05-22 9:36 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
6,944 | $0 | 76,390 (Direct) |
View |
| 2023-01-11 Option Award |
2023-05-19 9:17 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
83,334 | $0 | 350,489 (Direct) |
View |
| 2023-05-17 Exercise |
2023-05-19 9:17 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
25,500 | $0 | 350,489 (Direct) |
View |
| 2023-02-17 Exercise |
2023-02-23 5:40 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
25,498 | $0 | 196,392 (Direct) |
View |
| 2022-11-17 Exercise |
2022-11-21 4:17 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
5,805 | $0 | 196,148 (Direct) |
View |
| 2022-07-02 Gift |
2022-09-07 4:50 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
6,500 | $0 | 110,858 (Direct) |
View |
| 2022-08-17 Exercise |
2022-08-19 4:58 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
5,805 | $0 | 203,261 (Direct) |
View |
| 2022-05-17 Option Award |
2022-05-19 4:55 pm |
N/A 2032-05-16 |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
154,800 | $0 | 154,800 (Direct) |
View |
| 2021-04-29 Gift |
2021-05-28 5:23 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
4,750 | $0 | 354,670 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 5:23 pm |
N/A 2031-05-25 |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
200,000 | $0 | 354,670 (Direct) |
View |
| 2021-02-07 Option Award |
2021-02-08 9:32 pm |
N/A 2029-05-15 |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
115,000 | $0 | 115,000 (Direct) |
View |
| 2020-10-29 Gift |
2021-01-06 5:33 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
6,000 | $0 | 179,420 (Direct) |
View |
| 2020-12-16 Option Award |
2020-12-18 5:58 pm |
N/A 2030-06-16 |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
140,000 | $0 | 140,000 (Direct) |
View |
| 2020-04-29 Gift |
2020-10-20 2:08 pm |
N/A N/A |
KalVista Pharmaceuticals Inc. | KALV | Crockett Thomas Andrew CEO |
3,000 | $0 | 233,959 (Direct) |
View |